Clinical significance of ventricular fibrillation-flutter induced by ventricular programmed stimulation
dc.contributor.author | DiCarlo, Jr. , Lorenzo A. | en_US |
dc.contributor.author | Morady, Fred | en_US |
dc.contributor.author | Schwartz, Alan B. | en_US |
dc.contributor.author | Shen, Edward N. | en_US |
dc.contributor.author | Baerman, Jeffrey M. | en_US |
dc.contributor.author | Krol, Ryszard B. | en_US |
dc.contributor.author | Scheinman, Melvin M. | en_US |
dc.contributor.author | Sung, Ruey J. | en_US |
dc.date.accessioned | 2006-04-07T19:06:11Z | |
dc.date.available | 2006-04-07T19:06:11Z | |
dc.date.issued | 1985-05 | en_US |
dc.identifier.citation | DiCarlo, Jr., Lorenzo A., Morady, Fred, Schwartz, Alan B., Shen, Edward N., Baerman, Jeffrey M., Krol, Ryszard B., Scheinman, Melvin M., Sung, Ruey J. (1985/05)."Clinical significance of ventricular fibrillation-flutter induced by ventricular programmed stimulation." American Heart Journal 109(5, Part 1): 959-963. <http://hdl.handle.net/2027.42/25695> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6W9H-4BT98TC-18/2/c02112858a59272ebfbe8ebba80d3e50 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/25695 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3993530&dopt=citation | en_US |
dc.description.abstract | Two hundred twenty-four patients underwent ventricular programmed stimulation (VPS) without prior documentation of the clinical occurrence of sustained ventricular tachycardia (VT) or ventricular fibrillation-flutter (VF). Indications for VPS were: palpitations or nonsustained VT during ambulatory monitoring (85 patients), syncope or presyncope (137 patients), and a family history of sudden death (two patients). Sustained VF requiring transthoracic defibrillation was initiated by VPS in 18 patients (8.0%). Four patients were treated for inducible VF with antiarrhythmic agents directed by electropharmacologic testing; five patients were treated empirically; nine patients received no therapy. No patient has had a cardiac arrest or sudden death during a follow-up period of 25.2 +/- 13.8 months (mean +/- standard deviation). VF was initiated by two ventricular extrastimuli in three patients and by three extrastimuli in 15 patients. The incidence of VF was similar in patients with and without previous symptoms (8.8% vs 6.9%) or heart disease (7.1% vs 9.6%). It was significantly higher when VPS at three ventricular sites with a current of 5 mA (pulse width 2 msec) was compared to programmed stimulation at two ventricular sites with a current twice diastolic threshold (pulse width 2 msec) (15.2% vs 3.0%, p < 0.05). VF initiated by VPS in patients without prior VT or VF appears to be a nonspecific finding. Antiarrhythmic therapy for VF may not be necessary in these patients. | en_US |
dc.format.extent | 1141597 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Clinical significance of ventricular fibrillation-flutter induced by ventricular programmed stimulation | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Medicine, University of California, San Francisco, Calif., USA; Cardiovascular Research Institute, University of California, San Francisco, Calif., USA; The Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Mich., USA | en_US |
dc.contributor.affiliationum | Department of Medicine, University of California, San Francisco, Calif., USA; Cardiovascular Research Institute, University of California, San Francisco, Calif., USA; The Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Mich., USA | en_US |
dc.contributor.affiliationum | Department of Medicine, University of California, San Francisco, Calif., USA; Cardiovascular Research Institute, University of California, San Francisco, Calif., USA; The Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Mich., USA | en_US |
dc.contributor.affiliationum | Department of Medicine, University of California, San Francisco, Calif., USA; Cardiovascular Research Institute, University of California, San Francisco, Calif., USA; The Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Mich., USA | en_US |
dc.contributor.affiliationum | Department of Medicine, University of California, San Francisco, Calif., USA; Cardiovascular Research Institute, University of California, San Francisco, Calif., USA; The Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Mich., USA | en_US |
dc.contributor.affiliationum | Department of Medicine, University of California, San Francisco, Calif., USA; Cardiovascular Research Institute, University of California, San Francisco, Calif., USA; The Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Mich., USA | en_US |
dc.contributor.affiliationum | Department of Medicine, University of California, San Francisco, Calif., USA; Cardiovascular Research Institute, University of California, San Francisco, Calif., USA; The Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Mich., USA | en_US |
dc.contributor.affiliationum | Department of Medicine, University of California, San Francisco, Calif., USA; Cardiovascular Research Institute, University of California, San Francisco, Calif., USA; The Cardiac Electrophysiology Section, Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor Mich., USA | en_US |
dc.identifier.pmid | 3993530 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/25695/1/0000249.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0002-8703(85)90235-2 | en_US |
dc.identifier.source | American Heart Journal | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.